Back to 
Two Sigma Investments, LP
Two Sigma Investments, LP
CLDX
Showing 0 of 2 quarters
Position history for Two Sigma Investments, LP's holdings in Celldex Therapeutics, Inc.
As of its Q4 2018 13F, Two Sigma Investments held 1,741,075 shares of CLDX (Celldex Therapeutics), worth $345,000.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.